12082645 · Active · incorporated 7 years, 3 months ago · London
Biotech Biotech & Life Sciences Deep Tech Drug Discovery Series B+
Myricx Bio is a biotechnology company developing small molecule inhibitors for cancer treatment, based on NMT technology.
Myricx Bio is a private limited company registered at Companies House under number 12082645, incorporated on 3 July 2019, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 105 filings for this company, including 7 funding rounds. Its most recent round closed in August 2026, raising £640k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Aug 2026 | £640k | £0.125 |
| Round 6 | Feb 2026 | £39.6m | £0.125 |
| Round 5 | Jun 2025 | £30m | £1.25 |
| Round 4 | Jun 2024 | £20.8m | £1.25 |
| Round 3 | Aug 2023 | £8.7m | £1.00 |
| Round 2 | May 2021 | £500k | £1.00 |
Showing the 6 most recent of 7 rounds.
Showing the 16 most recent of 105 filings.
See the complete cap table with every shareholder, founder tags, dilution across 33 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.